OM1
Tom Engel is the Vice President of Business Development for OM1, Inc. Previously, Tom led the US Sales Team for QuintilesIMS Real World Evidence following the merger of Quintiles and IMS Health. Prior to the merger, Tom led the North America Sales Team for Real World and Late Phase Research at Quintiles (NYSE: Q), the world's largest Clinical Research Organization (CRO). In 2004, Tom joined Rich Gliklich at Outcome Sciences, Inc. (Outcome) where he focused on sales and market development through the 2011 acquisition of Outcome by Quintiles.
In 1998, Tom joined Phase Forward (later acquired by Oracle) as the first Product Manager for InForm, the market-leading electronic data capture system for clinical development. He joined IntraLinks, Inc. in 2002 as Vice President of Strategic Business Development tasked to develop new sales channels for IntraLinks’ clinical products.
Tom received his Bachelor of Arts degree from Boston College in Mathematics a very long time ago.
This person is not in any offices
OM1
2 followers
OM1 is a leading health outcomes and registries company focused on the measurement, comparison, and prediction of treatment outcomes. Leveraging big data, standardized outcomes measurement, and artificial intelligence technology, OM1 built the first intelligent data cloud for healthcare, enabling more precise information and better decision-making for stakeholders across the healthcare ecosystem.